Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 试验地点
- 6
- 主要终点
- Assessment of pronostic impact of nuclear grade in comparison with combined grade in peritoneal malignant mesothelioma
研究概览
简要总结
Malignant peritoneal mesothelioma is a rare neoplasm. The most common type, the epithelioid type, has been further divided into histological patterns of tubulo-papillary, acinar, adenomatoid, micropapillary, or solid. Its prognosis is improved by the use of a locoregional treatment combining extensive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which increases survival up to 50 months. Histology is one of the most important prognostic variable that, forms the basis for treatment decisions. However, the prognostic of the epithelioid type varies greatly due to its tumor heterogeneity. It is therefore necessary to find prognostic factors of malignant epithelioid peritoneal mesothelioma in order to better define the therapeutic strategy. Among histological factors, solid growth, tumor necrosis, nuclear atypia, and mitotic count were found to be independent prognostic factors in epithelioid malignant pleural mesothelioma. However, in epithelioid malignant peritoneal mesothelioma (EMPM), these factors were studied in small and heterogeneous series in terms of histological growth and definitions used for histological factors. The present large study was conducted to investigate the prognostic impact of several histologic factors in EMPM. Their prognosis impacts were assessed using overall survival (OS) and progression-free survival (PFS) in EMPM.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- peritoneal malignant mesothelioma
排除标准
- •opposition to reuse personnal data
结局指标
主要结局
Assessment of pronostic impact of nuclear grade in comparison with combined grade in peritoneal malignant mesothelioma
时间窗: 3 months to 4 years
Assessment by the review of pathologists
次要结局
未报告次要终点
